Dr. Chin Hin NG

Dr Ng Chin Hin is a Senior Consultant Haematologist who specialises in Leukaemia and other blood cancers. He was the Leukaemia Lead at National University Cancer Institute of Singapore (NCIS) and has more than 10 years experience in this field.  He is active in clinical research and was the Research Director for the Haematology Division in the Department of Haematology-Oncology at NCIS. In addition, he was also actively involved in undergraduate training and was an Assistant Professor at Yong Loo Lin School of Medicine, National University of Singapore.

Dr Ng is passionate about improving the outcome of acute leukaemia by means of MRD-guided therapy and optimising the use of novel targeted therapy. He firmly believes that MRD-guided treatment of Acute Leukaemia in combination with novel targeted therapy provides optimum treatment outcome and minimises unnecessary toxicity.|

Qualifications

• MD, Universiti Malaysia Sarawak, 2000
• Member of The Royal College of Physicians (UK), 2005
• Advanced Specialist Training – Haematology, JCST Singapore
• Registered Specialist in Haematology, Singapore Medical Council, 2010
• Master In Clinical Investigation (National University of Singapore), 2012
• Fellow of The Royal College of Pathologists – Haematology Subspecialty (UK), 2013

Background

• Local and regional key opinion leader in the treatment and management of Leukaemia
• Leukaemia Lead and the Research Director for Haematology Division in National University Cancer Institute of Singapore (2013-2020)
• Chairperson for the Leukemia Tumour Board of National University Cancer Institute of Singapore (2013-2020)
• Member of the advisory boards in major pharmaceutical companies
• Principal investigator of clinical trials involving novel agents in the treatment of Acute Leukaemia
• Fellowship at Early Phase Clinical Trial Unit of University College London Hospital (2015 – 2016)
• Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore (2016-2020)